Atomoxetine, Serum or Plasma
Also known as: Strattera®
Use
Therapeutic drug management
Special Instructions
Not provided.
Limitations
Therapeutic range has not been established. Results may be significantly affected by CYP2D6 metabolizer status, resulting in higher steady-state levels in poor metabolizers. In some cases, additional confirmatory or reflex testing may extend turnaround time.
Methodology
Mass Spectrometry
Biomarkers
Atomoxetine
Analyte
LOINC Codes
- 35667-5 - Atomoxetine SerPl-mCnc
- 35667-5 - Atomoxetine SerPl-mCnc
Result Turnaround Time
7-10 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
0.5 mL
Container
Red-top tube or green-top (heparin) tube. Gel-barrier tubes are not recommended.
Collection Instructions
Serum or plasma should be separated from cells within two hours of venipuncture. Submit serum or plasma in a plastic transport tube.
Patient Preparation
Trough levels are most reproducible.
Storage Instructions
Submission/transport (<3 days): Room temperature. For storage beyond three days, specimen should be refrigerated or frozen.
Causes for Rejection
Gel-barrier tubes
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 3 days |
| Refrigerated | 7 days |
| Frozen | 6 months |
Other tests from different labs that may be relevant